Characteristics of clinical subjects for MRM-MS analysis.

Abbreviations TACE: Transcatheter arterial chemoembolization. PEIT: Percutaneous ethanol injection therapy. RFA: Radiofrequency ablation. AFP: Alpha-fetoprotein. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase. CR: Complete Response; PR: Partial Response; SD: Stable disease; PD: Progressive disease. Albumin, Bilirubin, AST, ALT, ALP, and HBV DNA levels data are presented as mean ± SD. aHBV DNA levels were provided for 26 among a total of 35 liver cirrhosis patients, and 29 among the 60 HCC patients. bAntiviral therapy was treatment with Entecavir, Tenofovir, Zeffix, Hepsera and Revovir. cTumor size was provided for 40 among a total of 60 HCC patients. dAccording to American Joint Committee on Cancer (AJCC) staging system (7th edition, 2010). Characteristics of clinical subjects for MRM-MS analysis.